USPTO serial 79361080
LEOBRAIN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 9, 2024
- Examiner
- EUBANK, REBECCA A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LEOBRAIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for database management, organizing, accessing, recording, and evaluating patient data, managing patient files, and managing the operation of medical facilities for use in healthcare and for medical applications; recorded software for operating, monitoring respiratory apparatus software; recorded computer software for controlling or regulating medical ventilators; downloadable computer software for database management for use in the medical field; downloadable computer software for the remote monitoring of medical measuring apparatus; downloadbale computer software for monitoring medical equipment used in connection with patient management; downloadable computer software for analyzing, organizing, accessing, recording patient data and therapy data; optical fibre sensors; photoelectric sensors; calorimeters | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, for monitoring vital signs, blood properties, and respiratory events; sleep diagnostics apparatus, namely, respiratory monitors, respiratory effort sensors, airflow sensors, snore detectors, and electrodes; sleep respiratory therapy apparatus, namely, continuous positive airway pressure (CPAP) devices, automatic positive airway pressure (APAP) devices; respiratory therapy instruments, namely, ventilators, humidifiers for medical use, respiratory equipment and monitors therefor, lung ventilators with monitoring capability, oxygen monitors for medical use, nebulizers for respiration therapy; pneumology apparatus, namely, ventilators, humidifiers for medical use, medical apparatus for diagnosing or treating respiratory conditions, respiratory equipment and monitors therefor, nasal continuous positive airway (CPAP) devices, lung ventilators with monitoring capability, oxygen monitors for medical use; neonatology apparatus, in particular incubators, heat beds, heat emitters; apparatus for oxygen therapy, namely, oxygen concentrators, oxygen therapy masks, ventilators, humidifiers for medical use, respiratory equipment and monitors therefor, lung ventilators with monitoring capability, oxygen monitors for medical use, nebulizers for respiration therapy; face masks in the nature of inhalation and breathing equipment for anaesthesia and for respiratory or oxygen therapy; resuscitation apparatus; resuscitation units; respiratory apparatus, namely, continuous positive airway pressure (CPAP) devices, automatic positive airway pressure (APAP) devices, ventilators, humidifiers for medical use, respiratory equipment and monitors therefor, lung ventilators with monitoring capability, oxygen monitors for medical use, nebulizers for respiration therapy; anaesthetic apparatus; inhalers, for medical purposes, sold empty; medical apparatus and instrument accessories, namely, test apparatus for breathing apparatus, anaesthesia apparatus and inhalation apparatus; diagnostic, examination and monitoring apparatus for medical purposes, namely, medical apparatus for monitoring vital signs of patients, medical devices for monitoring vital signs, blood properties and respiratory events; monitoring apparatus for assessing respiratory metabolic function, namely, respirometers; apparatus for measuring, monitoring and logging basic human functions and physiological variables, namely, medical apparatus for monitoring vital signs of patients, medical devices for monitoring vital signs, blood properties and respiratory events; monitoring apparatus for assessing the metabolism, namely, medical diagnostic instruments for the analysis of body fluids, medical instruments for cardiovascular diagnostics, breath gas analyzers for medical diagnostics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Löwenstein Medical Technology S.A.
- Other trademarks owned by Löwenstein Medical Technology S.A.
- Other trademarks owned by Löwenstein Medical Technology S.A.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named LEOBRAIN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 17, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 31, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 31, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 19, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 9, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 9, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 22, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 3, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 3, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 15, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 11, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 10, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 10, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 4, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 13, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 13, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 8, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 7, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 3, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 31, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 27, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 26, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |